Arvin Ighani

11PUBLICATIONS
6CO-AUTHORS
Pharmaceutical delivery technologiesMolecular medicinePharmacology and pharmaceutical sciences not elsewhere classifiedClinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 23, 2020
Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort Study.

Christine E Jo, Jorge R Georgakopoulos, Matthew Ladda

|May 05, 2019
Off-label Uses of Topical Pimecrolimus.

Matthew Ladda, Vijay Sandhu, Arvin Ighani

|Apr 18, 2019
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis.

Michelle Phung, Arvin Ighani, Jorge R Georgakopoulos

|Feb 26, 2019
Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.

Arvin Ighani, Ashley M Yu, Vijay K Sandhu

|Nov 20, 2018
Ixekizumab (Interleukin 17A Antagonist): 12-week Efficacy and Safety Outcomes in Real-world Clinical Practice.

Jorge R Georgakopoulos, Michelle Phung, Arvin Ighani

|Oct 27, 2018
Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study.

A Ighani, D Al-Mutairi, A Rahmani

Pageof 2

Frequent Collaborators

2 joint publications

Jorge R Georgakopoulos

2 joint publications

Vijay Sandhu

2 joint publications

Matthew Ladda

1 joint publications

Neil Shear